All-Case Surveillance Lifted for Humira for Crohn’s Disease: Abbott Japan/Eisai

October 31, 2012
Abbott Japan and Eisai announced on October 29 that the two companies have received a notification from the Ministry of Health, Labor and Welfare (MHLW) informing them that the ministry has lifted the drug use-result survey (all-case surveillance) condition required...read more